Long‐Term Excretion of Roxadustat in Urine
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Tim Sobolevsky und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, UCLA Olympic Analytical Laboratory, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Glycine, Isoquinolines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Roxadustat (FG‐4592), an orally active hypoxia‐inducible factor prolyl hydroxylase stabilizer, has been shown to enhance erythropoiesis by increasing endogenous erythropoietin. It is indicated for the treatment of anemia and chronic kidney disease and is approved for clinical use in several countries, including the European Union, Japan and others. Due to its reasonably anticipated performance‐enhancing effect in athletes, roxadustat is prohibited for use in sports at all times. A few cases of adverse analytical findings in routine doping controls have been reported worldwide, some of which were claimed to be the result of contaminated dietary supplements. The present study offers new data demonstrating the long‐term excretion pattern of roxadustat. Even after a single‐dose administration, roxadustat can remain detectable in urine for 8 months, albeit at very low concentrations (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, UCLA Olympic Analytical Laboratory, Los Angeles, California, USA.
- Science and Research Department, US Anti-Doping Agency, Colorado Springs, Colorado, USA.
- Department of Nephrology and Dialysis, MVZ DaVita Rhein-Ruhr GmbH, Düsseldorf, Germany.
- Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
ORCID-Profile: Tim Sobolevsky, Matthew Fedoruk, Mario Thevis
Zitieren
APA
Sobolevsky, T., Fedoruk, M., Dellanna, F., Geyer, H., Ahrens, B., & Thevis, M. (2025). Long‐Term Excretion of Roxadustat in Urine. Drug Testing and Analysis. https://doi.org/10.1002/dta.3813
Vancouver
Sobolevsky T, Fedoruk M, Dellanna F, Geyer H, Ahrens B, Thevis M. Long‐Term Excretion of Roxadustat in Urine. Drug Testing and Analysis. 2025. doi:10.1002/dta.3813
BibTeX
@article{Sobolevsky2025,
author = {Sobolevsky, Tim and Fedoruk, Matthew and Dellanna, Frank and Geyer, Hans and Ahrens, Brian and Thevis, Mario},
title = {Long‐Term Excretion of Roxadustat in Urine},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3813}
}
EUVIMED